Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.
2.
4.

Azithromycin versus amoxicillin/clavulanate in the treatment of acute sinusitis.

Klapan I, Culig J, Oresković K, Matrapazovski M, Radosević S.

Am J Otolaryngol. 1999 Jan-Feb;20(1):7-11.

PMID:
9950107
5.

Efficacy, safety and tolerability of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections.

Ferwerda A, Moll HA, Hop WC, Kouwenberg JM, Tjon Pian Gi CV, Robben SG, de Groot R.

J Antimicrob Chemother. 2001 Apr;47(4):441-6.

PMID:
11266417
7.

Single-dose extended-release azithromycin versus a 10-day regimen of amoxicillin/clavulanate for the treatment of children with acute otitis media.

Arguedas A, Soley C, Kamicker BJ, Jorgensen DM.

Int J Infect Dis. 2011 Apr;15(4):e240-8. doi: 10.1016/j.ijid.2010.12.003. Epub 2011 Jan 26.

8.

Randomized, double-blind study of the clinical efficacy of 3 days of azithromycin compared with co-amoxiclav for the treatment of acute otitis media.

Dunne MW, Latiolais T, Lewis B, Pistorius B, Bottenfield G, Moore WH, Garrett A, Stewart TD, Aoki J, Spiegel C, Boettger D, Shemer A.

J Antimicrob Chemother. 2003 Sep;52(3):469-72. Epub 2003 Jul 29.

PMID:
12888586
9.

Effect of amoxicillin-clavulanate in clinically diagnosed acute rhinosinusitis: a placebo-controlled, double-blind, randomized trial in general practice.

Bucher HC, Tschudi P, Young J, Périat P, Welge-Lüussen A, Züst H, Schindler C; BASINUS (Basel Sinusitis Study) Invetigators.

Arch Intern Med. 2003 Aug 11-25;163(15):1793-8.

PMID:
12912714
10.

High-dose azithromycin versus high-dose amoxicillin-clavulanate for treatment of children with recurrent or persistent acute otitis media.

Arrieta A, Arguedas A, Fernandez P, Block SL, Emperanza P, Vargas SL, Erhardt WA, de Caprariis PJ, Rothermel CD.

Antimicrob Agents Chemother. 2003 Oct;47(10):3179-86.

11.
13.

A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome.

Hoepelman IM, Möllers MJ, van Schie MH, Greefhorst AP, Schlösser NJ, Sinninghe Damsté EJ, van de Moosdijk CN, Dalinghaus WH, Eland ME, Mol SJ, Rozenberg-Arska M.

Int J Antimicrob Agents. 1997 Jan;9(3):141-6.

PMID:
9552709
14.
15.

Comparison of two dosages of azithromycin for three days versus penicillin V for ten days in acute group A streptococcal tonsillopharyngitis.

Cohen R, Reinert P, De La Rocque F, Levy C, Boucherat M, Robert M, Navel M, Brahimi N, Deforche D, Palestro B, Bingen E.

Pediatr Infect Dis J. 2002 Apr;21(4):297-303.

PMID:
12075760
17.
18.

Large dosage amoxicillin/clavulanate, compared with azithromycin, for the treatment of bacterial acute otitis media in children.

Hoberman A, Dagan R, Leibovitz E, Rosenblut A, Johnson CE, Huff A, Bandekar R, Wynne B.

Pediatr Infect Dis J. 2005 Jun;24(6):525-32.

PMID:
15933563
20.

Supplemental Content

Support Center